Shirley Lanning

BSc (Hons 1), PhD, FAICD

Shirley has been an independent director of Autism CRC since its inception in 2013. During this time, she has served on the Research and Development Committee, the Remuneration, Nominations and Selection Committee, the Autism CRC Access Committee and the Governance Program Management Committee.

She brings extensive experience in corporate governance, marketing and communications, business development, research management and commercialization in commercial and not-for-profit organisations in the UK and Australia.

She has served as a non-executive Board Director of a number of not-for-profit organisations, including NanoVentures Australia, Nanotechnology Victoria, the Pig Research and Development Corporation and AusBiotech, and as a Member of Government Advisory Councils, including the Federal Government’s Advisory Council on Intellectual Property and the Victorian Cancer Agency Consultative Council. Before moving to Australia, she was the inaugural Executive Director of the UK BioIndustry Association.

Shirley has been involved with the CRC Program for many years, serving as Federal Government Visitor to the CRC for Viticulture and the CRC for Cellular Growth Factors. She is a Fellow of the Australian Institute of Company Directors.

“I believe the CRC is an effective model to address the complex challenges presented by autism and am confident that the outcomes of its research programs will provide significant benefits for the autistic community. I feel privileged to be part of this unique multidisciplinary initiative.”